"One year after appearing on South Park, the median stock underperforms the S&P 500 by 7%," Spectra Markets said.
South Park: The End of Obesity special released last week tackled the growing popularity of Ozempic and Mounjaro as Eric Cartman tries to get his hands on the hugely popular weight-loss drugs.
Advertisement"One year after appearing on South Park, the median stock underperforms the S&P 500 by 7%," Spectra Markets President Brent Donnelly said.
"South Park has a 20+ year history of capturing the cultural zeitgeist and it's impossible to argue that anything that is lampooned on South Park is not priced in," Donnelly said.
But not all those featured on South Park saw their stock prices peak shortly thereafter, with Microsoft, Yelp, and Netflix bucking the trend.
Persons:
—, Eric Cartman, Brent Donnelly, Donnelly, Eli Lilly, shouldn't
Organizations:
Service, Spectra Markets, Novo Nordisk, Twitter, Starbucks, Walmart, Microsoft, Netflix